The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2',4'-Difluoro-N-(3-(hydroxymethyl)-2-methylphenyl)-2-methylbiphenyl-4-sulfonamide ID: ALA2322464
PubChem CID: 71717422
Max Phase: Preclinical
Molecular Formula: C21H19F2NO3S
Molecular Weight: 403.45
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(S(=O)(=O)Nc2cccc(CO)c2C)ccc1-c1ccc(F)cc1F
Standard InChI: InChI=1S/C21H19F2NO3S/c1-13-10-17(7-9-18(13)19-8-6-16(22)11-20(19)23)28(26,27)24-21-5-3-4-15(12-25)14(21)2/h3-11,24-25H,12H2,1-2H3
Standard InChI Key: KYRMVXGYVJOWEP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
3.5532 -5.8518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2678 -5.4523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2785 -4.6340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5741 -4.2190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8620 -4.6239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8555 -5.4384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9946 -4.2318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7005 -4.6565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4160 -4.2555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4236 -3.4317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7130 -3.0141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0019 -3.4186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1396 -3.0294 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.8457 -3.4301 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7391 -2.3164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8447 -4.2485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1338 -4.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1276 -5.4729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8390 -5.8843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5525 -5.4700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5512 -4.6519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2600 -5.8813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2611 -6.7018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2597 -4.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5404 -2.3195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5804 -3.4018 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.1439 -5.8402 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.6879 -5.4736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 1 0
21 24 1 0
13 25 2 0
4 26 1 0
6 27 1 0
8 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.45Molecular Weight (Monoisotopic): 403.1054AlogP: 4.54#Rotatable Bonds: 5Polar Surface Area: 66.40Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.83CX Basic pKa: ┄CX LogP: 4.65CX LogD: 4.53Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.66Np Likeness Score: -1.43
References 1. Greig IR, Coste E, Ralston SH, van 't Hof RJ.. (2013) Development of triarylsulfonamides as novel anti-inflammatory agents., 23 (3): [PMID:23265887 ] [10.1016/j.bmcl.2012.11.067 ]